EverEdge IP assisted a major New Zealand tertiary Technology Transfer Office (TTO) on a bio-technology licensing case against a tight deadline. Providing valuable advice on the intellectual property position of the niche technology and advising on critical terms for the license, the TTO is one step ahead of the licensee and poised to negotiate a better deal as a result.
The client is a Technology Transfer Office (TTO) of one of New Zealand's largest Universities. Its role is to commercialise and generate revenue from the research and development efforts of the University.
The TTO was approached by an offshore nutra¬ceutical company interested in licensing one of its biotech patents. Uncertain of the potential market and what the commercial terms of the license should be, the TTO needed more information before entering negotiations and turned to EverEdge Intellectual Property for help. The TTO needed accurate information and clear strategic advice and the project had to be delivered against a tight time frame.
EverEdge IP prepared a comprehensive brief outlining exactly the information required and the outputs that needed to be reached. After gathering key facts from the TTO, we rapidly conducted research in the relevant fields; examining the market potential, the intellectual property landscape of the technology and the universe of analogous deals that had recently been completed. The goal was to determine critical values for the terms of the negotiation, the likely set of settlement ranges for the deal and from this develop a clear strategy to guide the TTO in the license negotiations.
EverEdge IP used its knowledge network to contact experts in New Zealand and the United States, as well as its own extensive knowledge base to deliver a comprehensive and accurate set of recommendations, data points and guide points within the deadline.
EverEdge IP enabled the client to enter licensing negotiations in a strong and well informed position.